BioMérieux researchers describe rise of multi-drug resistant Candida auris infections
Researchers at diagnostic company BioMérieux conducted a retrospective analysis of blood cultures positive for Candida auris (C. auris) and found an upsurge in the detection of this emerging fungal pathogen between 2021 and 2023. Read More
Chikungunya vaccine candidate in clinical trial found generally safe and effective
A study of U.S. adults found that a vaccine candidate for chikungunya disease was generally safe and well tolerated. Read More
Conferences
Science Briefs
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
